2Wofsy D, Kerger CE, Seaman WE. Monocytosis in the BXSB model for systemic lupus erythematosus [J]. J Exp Med,1984, 159: 629-634.
3Nelson JL, Torrez R, Louie FM, et al. Pre-existing autoimmune disease in patients with longterm survival after allogenic bone marrow transplantation [J]. J Rheumatol,1997, 24: 23-29.
4Sugihara A, Adachi Y, Inaba M, et al. Age-dependent abnormalities of hematopoietic stem cells in (NZW × BXSB)F1 mice [J]. Stem Cells, 1999, 17: 357-365.
5Ikehara S, Kawamura M, Takao K, et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells [J]. Proc Natl Acad Sci U S A,1990, 87: 8341-8344.
6Stohl W, Metyas S, Tan SM, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations [J]. Arthritis Rheum, 2003, 48 (12): 3475-3486.
7Stohl W. Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders [J].Expert Opin Ther Targets, 2004, 8 (3): 177-189.
8Khare SD, Sarosi I, Xia XZ, et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice [J]. Proc Natl Acad Sci U S A, 2000, 97 (7): 3370-3375.
